Binding Kinetics of ZM241385 Derivatives at the Human Adenosine A2AReceptor
- 3 March 2014
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 9 (4) , 752-761
Abstract
Classical drug design and development rely mostly on affinity‐ or potency‐driven structure–activity relationships (SAR). Thus far, a given compound’s binding kinetics have been largely ignored, the importance of which is now being increasingly recognized. In the present study, we performed an extensive structure–kinetics relationship (SKR) study in addition to a traditional SAR analysis at the adenosine A2Areceptor (A2AR). The ensemble of 24 A2AR compounds, all triazolotriazine derivatives resembling the prototypic antagonist ZM241385 (4‐(2‐((7‐amino‐2‐(furan‐2‐yl)‐[1,2,4]triazolo[1,5‐a][1,3,5]triazin‐5‐yl)amino)ethyl)phenol), displayed only minor differences in affinity, although they varied substantially in their dissociation rates from the receptor. We believe that such a combination of SKR and SAR analyses, as we have done with the A2AR, will have general importance for the superfamily of G protein‐coupled receptors, as it can serve as a new strategy to tailor the interaction between ligand and receptor.Keywords
This publication has 43 references indexed in Scilit:
- Structure and dynamics of the M3 muscarinic acetylcholine receptorNature, 2012
- Pathway and mechanism of drug binding to G-protein-coupled receptorsProceedings of the National Academy of Sciences, 2011
- Adenosine A2A Receptor Antagonists and Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- Recent developments in adenosine receptor ligands and their potential as novel drugsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Structure of an Agonist-Bound Human A2AAdenosine ReceptorScience, 2011
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An UpdatePharmacological Reviews, 2011
- Fast on-rates allow short dwell time ligands to activate T cellsProceedings of the National Academy of Sciences, 2010
- Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M3 ReceptorMolecular Pharmacology, 2009
- SAR of a series of inhaled A2A agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic dataBioorganic & Medicinal Chemistry Letters, 2009
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973